Treatment with CXCL13 antibody dramatically diminished the effects of RA synovial fluid upon EPC migration and tube formation (VEGF-induced EPC migration and tube formation served as the positive control) (Fig. 1D and E). Here, VEGFA is linked to rheumatoid arthritis.